Presentation to review historic issues related to glaucoma therapies and how these may be addressed through the use of Optejet®...
Global study will evaluate UX143 in pediatric and young adult patients ages 5 to NOVATO, Calif., April 20, 2022 (GLOBE...
HITRUST Risk-based, 2-year Certification validates Healthcare Triangle is committed to meeting key regulations and protecting sensitive informationPLEASANTON, Calif., April 20,...
MARIETTA, Ga., April 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental...
Press release Malmö, Sweden, April 20, 2022 Acarix publishes the annual report for 2021 Today, Wednesday April 20, Acarix is publishing...
CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
FLORHAM PARK, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a...
Company to showcase efficacy of its precision Oral Appliance Therapy devices in treating Obstructive Sleep ApneaSAN FRANCISCO, April 20, 2022 (GLOBE...
Elusys becomes wholly-owned biodefense subsidiary of NightHawk Plans to expand ANTHIM® distribution abroad DURHAM, N.C., April 20, 2022 (GLOBE NEWSWIRE)...
Groundbreaking partnership includes debut of Lowell Farms-branded lighters within the Zippo portfolioSALINAS, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- In a...
New services include pathogen identification, microbiome profiling and rapid turnaround sequencing of clinical isolatesROCKVILLE, Md., April 20, 2022 (GLOBE NEWSWIRE)...
*** David Reardon, Luigi Naldini, Brad Loncar ***MILAN, Italy and NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- Genenta Science...
Clinical benefit again observed for OTO-413 versus placebo for multiple efficacy endpoints based on responder analysis at both Days 57...
Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital
--94% cumulative protective effect against COVID-19 in previously-infected individuals that subsequently received Clover’s COVID-19 vaccine candidate-- --First and only COVID-19...
- 356 IPF Patients Enrolled - - Topline Data Anticipated Mid-2023 - SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) --...
LOS ANGELES, April 20, 2022 (GLOBE NEWSWIRE) -- Enochian BioSciences (NASDAQ: ENOB). Enochian BioSciences Inc., a company focused on gene-modified...
Data Highlights Clinical Utility of CareDx Solutions, Including Findings from Surveillance HeartCare Outcomes Registry (SHORE) Demonstrating Power of Multimodality Assessment...
Over 40% of Long COVID Patients Had Fibromyalgia-Like Multi-Site Pain Symptoms Rate of Opioid Use in Long COVID Patients with...
OLINVYK showed a statistically significant reduced impact on respiratory function compared to IV morphine, among elderly/overweight subjects Data replicate observations...
